Menu
GeneBe

CDH15

cadherin 15, the group of Type I classical cadherins

Basic information

Region (hg38): 16:89171747-89195492

Previous symbols: [ "CDH3", "CDH14" ]

Links

ENSG00000129910NCBI:1013OMIM:114019HGNC:1754Uniprot:P55291AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • intellectual disability, autosomal dominant 3 (Limited), mode of inheritance: AD
  • autosomal dominant non-syndromic intellectual disability (Supportive), mode of inheritance: AD
  • intellectual disability, autosomal dominant 3 (Limited), mode of inheritance: AD
  • intellectual disability, autosomal dominant 3 (Limited), mode of inheritance: AD
  • intellectual disability (Disputed Evidence), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Intellectual developmental disorder, autosomal dominant 3ADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Musculoskeletal; Neurologic19012874

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CDH15 gene.

  • not provided (109 variants)
  • Inborn genetic diseases (66 variants)
  • not specified (49 variants)
  • Intellectual disability, autosomal dominant 3 (23 variants)
  • CDH15-related condition (5 variants)
  • Intellectual disability (1 variants)
  • Intellectual disability, autosomal dominant 1 (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDH15 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
34
clinvar
9
clinvar
45
missense
113
clinvar
27
clinvar
9
clinvar
149
nonsense
1
clinvar
1
start loss
1
clinvar
1
frameshift
6
clinvar
6
inframe indel
1
clinvar
2
clinvar
3
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
1
1
1
3
non coding
2
clinvar
2
clinvar
4
Total 0 0 127 65 18

Variants in CDH15

This is a list of pathogenic ClinVar variants found in the CDH15 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-89171833-T-A Uncertain significance (Aug 17, 2017)451434
16-89171853-G-C not specified Uncertain significance (May 04, 2022)1686549
16-89179418-C-G not specified Uncertain significance (Aug 30, 2022)2364912
16-89179449-A-C Likely benign (Nov 01, 2023)2672663
16-89179450-G-A not specified Uncertain significance (Jun 09, 2022)2294269
16-89179472-CT-C not specified Uncertain significance (May 04, 2022)1686550
16-89179480-G-A not specified • CDH15-related disorder Conflicting classifications of pathogenicity (Mar 27, 2023)210623
16-89179482-G-T not specified Benign (Feb 27, 2019)128642
16-89179483-C-T not specified Uncertain significance (Oct 05, 2023)3141110
16-89179484-G-A CDH15-related disorder Likely benign (Dec 01, 2023)3025587
16-89179500-G-A not specified Uncertain significance (Oct 29, 2021)2351962
16-89179500-G-T not specified Uncertain significance (Feb 27, 2023)872527
16-89179503-C-T not specified Uncertain significance (Sep 12, 2023)2588118
16-89179504-G-A Uncertain significance (-)1299870
16-89179505-G-T Likely benign (Apr 01, 2024)444387
16-89179525-C-T not specified Uncertain significance (May 08, 2023)2514779
16-89179526-G-A not specified Benign (Jan 23, 2020)128643
16-89179533-G-A Likely benign (Jan 01, 2024)739776
16-89179533-G-T Intellectual disability, autosomal dominant 1 Uncertain significance (-)2584664
16-89179538-C-T not specified Likely benign (Jan 09, 2020)1337506
16-89179544-C-T not specified Likely benign (-)128644
16-89179547-C-T not specified Likely benign (-)128645
16-89179551-C-T Intellectual disability, autosomal dominant 3 Likely benign (Jan 19, 2022)17642
16-89179552-G-A not specified Uncertain significance (Dec 19, 2022)2218907
16-89179556-C-T not specified Likely benign (Sep 06, 2020)1781118

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CDH15protein_codingprotein_codingENST00000289746 1423726
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.77e-140.18812548501791256640.000712
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.015915261.120.00003425153
Missense in Polyphen206203.331.01312052
Synonymous-2.202942501.180.00001791764
Loss of Function1.092531.60.7910.00000150321

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.003440.00343
Ashkenazi Jewish0.0001010.0000993
East Asian0.0007850.000762
Finnish0.00004720.0000462
European (Non-Finnish)0.0003160.000299
Middle Eastern0.0007850.000762
South Asian0.0003300.000327
Other0.0006580.000652

dbNSFP

Source: dbNSFP

Function
FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. M-cadherin is part of the myogenic program and may provide a trigger for terminal muscle differentiation.;
Disease
DISEASE: Note=A chromosomal aberration involving CDH15 and KIRREL3 is found in a patient with severe mental retardation and dysmorphic facial features. Translocation t(11;16)(q24.2;q24).; DISEASE: Mental retardation, autosomal dominant 3 (MRD3) [MIM:612580]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:19012874}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Cell adhesion molecules (CAMs) - Homo sapiens (human);Developmental Biology;CDO in myogenesis;Myogenesis;Cell-cell junction organization;Adherens junctions interactions;Cell junction organization;Cell-Cell communication (Consensus)

Recessive Scores

pRec
0.123

Intolerance Scores

loftool
0.663
rvis_EVS
-1.08
rvis_percentile_EVS
7.28

Haploinsufficiency Scores

pHI
0.126
hipred
N
hipred_score
0.486
ghis
0.614

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.830

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cdh15
Phenotype
normal phenotype;

Zebrafish Information Network

Gene name
cdh15
Affected structure
slow muscle cell
Phenotype tag
abnormal
Phenotype quality
elongated

Gene ontology

Biological process
cell morphogenesis;cell-cell junction assembly;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;adherens junction organization;cell-cell adhesion mediated by cadherin;positive regulation of muscle cell differentiation;cell-cell adhesion
Cellular component
Golgi apparatus;cytosol;plasma membrane;caveola;cell-cell adherens junction;cell surface;integral component of membrane;catenin complex;neuromuscular junction;extracellular exosome
Molecular function
calcium ion binding;protein binding;cytoskeletal protein binding;protein homodimerization activity;cadherin binding